Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc., which is a subsidiary) on June 7, 2013. The filing discloses corporate governance actions taken by the Board of Directors regarding executive compensation and equity grants for the fiscal year 2014.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity figures. It focuses exclusively on the structure of compensation plans and specific salary adjustments.
Material Changes and Compensation Actions
- 2014 Cash Bonus Plan: The Board approved a performance-based cash bonus plan for employees of Landec, Apio, Inc., and Lifecore Biomedical, Inc. Bonuses are contingent on exceeding revenue and consolidated net income targets for fiscal year 2014.
- Executive officers may earn up to 80% to 100% of base salary.
- Other employees may earn up to 18% to 80% of base salary.
- Participants must be employed at the end of fiscal year 2014 to receive payment.
- Equity Grants: The Board approved stock options and restricted stock units (RSUs) for named executive officers. Options vest monthly over three years; RSUs vest on the third anniversary.
Officer Title Stock Options RSUs Ronald Midyett President and CEO of Apio 30,000 10,000 Molly Hemmeter Chief Commercial Officer 30,000 10,000 Gregory Skinner Chief Financial Officer 30,000 10,000 Gary Steele President and CEO 45,000 15,000 - Salary Adjustment: Ronald Midyett's salary was increased to $330,000, effective May 27, 2013.
Guidance, Outlook, and Risks
The filing contains no forward-looking financial guidance, market outlook, or discussion of risks and contingencies. The primary contingency noted is that bonus payments are strictly dependent on achieving specific revenue and net income targets for fiscal year 2014.
Investor Verification Checklist
- Verify the specific revenue and net income targets for fiscal year 2014 required to trigger the cash bonus plan.
- Confirm the exercise price of the stock options granted to executive officers.
- Review the total number of shares available under the company's equity incentive plan to assess dilution impact.
- Check subsequent filings for the actual performance results of fiscal year 2014 to determine if bonuses were paid.